Sheran Mahatme, DO, MPH

Associate Professor

view physician profile

Locations

Froedtert Hospital
Zablocki VA Medical Center
Infectious Disease Clinic - Froedtert Hospital
Zablocki VA Medical Center

Specialties

Infectious Disease

Languages

English

Infectious Disease Clinic

(414) 805-6444

Education

DO - Doctor of Osteopathic Medicine
MPH - Masters in Public Health

Biography

Dr. Sheran Mahatme is a board certified Infectious Diseases (ID) physician with a specialized interest in HIV care. She completed her three year Infectious Diseases fellowship at the University of Pittsburgh in Pittsburgh, Pennsylvania in 2005. Her training was preceded by an Internal Medicine internship at Genesys Regional Medical Health Systems in Grand Blanc, Michigan and an Internal Medicine residency at Henry Ford Hospital in Detroit, Michigan. Dr. Mahatme holds a Masters of Public Health in Public and Community Health Services. She serves as the Chief of Infectious Diseases, HIV lead physician, and Associate Chief of Staff for Community Care at the Clement J. Zablocki VA Medical Center. Dr. Mahatme is an associate professor of medicine at the Medical College of Wisconsin. Her focus in care centers around HIV prevention, retention, and linkage to care, sexually transmitted infections, and medical education. Outside of work, Dr. Mahatme and her family enjoy traveling, cooking, seeking new “foodie” adventures, and attending various performances in the arts. She and her family also love spending time with their two mischievous dogs.

Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans.

(Ross JM, Sugimoto JD, Timmons A, Adams J, Deardoff K, Korpak A, Liu C, Moore K, Wilson D, Bedimo R, Chang KM, Cho K, Crothers K, Garshick E, Gaziano JM, Holodniy M, Hunt CM, Isaacs SN, Le E, Jones BE, Shah JA, Smith NL, Lee JS, EPIC Investigators .) Open Forum Infect Dis. 2023 Jul;10(7):ofad330 PMID: 37484899 PMCID: PMC10358428 SCOPUS ID: 2-s2.0-85167513052 07/24/2023
Understanding the relationship between patient characteristics and complication in veterans discharged on parenteral antibiotic therapy.

(Guenther ED, Sherman KA, Dysart CE, Haque J, Mahatme S, Gundacker ND.) Res Social Adm Pharm. 2022 Oct;18(10):3864-3866 PMID: 35437231 SCOPUS ID: 2-s2.0-85128266544 04/20/2022
The effects of beta-lactam allergy relabeling on antibiotic prescribing practices.

(Gaberino CL, Chiu AM, Mahatme SS.) Ann Allergy Asthma Immunol. 2022 Mar;128(3):307-313 PMID: 34890777 SCOPUS ID: 2-s2.0-85122084422 12/11/2021
Short Communication: Relationship Between Contraindicated Drug-Drug Interactions and Subsequent Hospitalizations Among Patients Living with HIV Initiating Combination Antiretroviral Therapy.

(Sangiovanni RJ, Jakeman B, Nasiri M, Ruth L, Mahatme S, Patel N.) AIDS Res Hum Retroviruses. 2019 May;35(5):430-433 PMID: 30612438 PMCID: PMC6508060 SCOPUS ID: 2-s2.0-85065167002 01/08/2019
Persistence of Schistosoma japonicum DNA in a Kidney-Liver Transplant Recipient.

(Kron M, Gordon C, Bauers T, Lu Z, Mahatme S, Shah J, Saeian K, McManus DP.) Am J Trop Med Hyg. 2019 Mar;100(3):584-587 PMID: 30628570 PMCID: PMC6402933 SCOPUS ID: 2-s2.0-85062624381 01/11/2019
Persistence of Schistosoma japonicum DNA in a Kidney–Liver Transplant Recipient

(Michael Kron, Catherine Gordon, Timothy Bauers, Zouyan Lu, Sheran Mahatme, Janaki Shah, Kia Saeian and Donald P. McManus .) . 01/07/2019
Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients.

(Jakeman B, Nasiri M, Ruth L, Morse C, Mahatme S, Patel N.) Ann Pharmacother. 2017 May;51(5):365-372 PMID: 28367698 SCOPUS ID: 2-s2.0-85017020529 04/04/2017
The Preliminary Impact of Pain Management Integration into an HIV Specialty Clinic

(Mahatme S, Atkinson T, Spallone A, and Fudin J.) The Scientific Pages of Anesthesia & Pain Management. 04/11/2017
Virus reactivation: a panoramic view in human infections.

(Traylen CM, Patel HR, Fondaw W, Mahatme S, Williams JF, Walker LR, Dyson OF, Arce S, Akula SM.) Future Virol. 2011 Apr;6(4):451-463 PMID: 21799704 PMCID: PMC3142679 07/30/2011
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.

(Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV.) Clin Infect Dis. 2008 Aug 01;47(3):421-4 PMID: 18558886 PMCID: PMC2586907 06/19/2008
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.

(Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW, ACTG A5086 Study Team.) J Infect Dis. 2006 Nov 01;194(9):1309-18 PMID: 17041858 10/17/2006
Inadvertent rupture of an echinococcal cyst: case report and review of literature.

(Patel SS, Butt AA.) Am J Med Sci. 2004 May;327(5):268-71 PMID: 15166748 05/29/2004